GOTHENBURG, Sweden--(BUSINESS WIRE)--Regulatory News: Vitrolife (STO:VITR) is now the first company to have received approval from the American Food and Drug Administration for products within the fertility area used for the rapid freezing and thawing of cleavage embryos (embryos on day 3 after fertilization), so-called vitrification.
